Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05312398
Title CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Campania "Luigi Vanvitelli"
Indications

colorectal adenocarcinoma

Therapies

Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Cetuximab + Irinotecan

Cetuximab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST